CIK 0001400118 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| FY2025 | FY2024 | FY2023 | |
|---|---|---|---|
| Revenue (USD) | 2.0 M | ||
| Net income (USD) | -51.0 M | -27.9 M | -30.5 M |
| Diluted EPS (USD/shares) | -1.58 | -2.66 | -165.2 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-22 | 8-K | 8-K items 7.01,9.01 | 2026-10-22 |
| 2026-10-07 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-10-01 | 8-K | 8-K items 1.01,9.01 | 2026-09-30 |
| 2026-10-01 | 424B5 | 424B5 | |
| 2026-09-30 | 8-K | 8-K items 7.01,8.01,9.01 | 2026-09-30 |
| 2026-09-30 | 424B3 | 424B3 | |
| 2026-08-17 | 4 | 4 | 2026-08-14 |
| 2026-08-14 | 144 | 144 | |
| 2026-08-14 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-08-13 | 8-K | 8-K items 8.01 | 2026-08-13 |
| 2026-08-12 | 4 | 4 | 2026-08-11 |
| 2026-08-11 | 144 | 144 | |
| 2026-08-11 | 8-K | 8-K items 2.02,7.01,9.01 | 2026-08-11 |
| 2026-08-11 | 10-Q | 10-Q | 2026-06-30 |
| 2026-07-30 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-07-22 | 4 | 4 | 2026-07-20 |
| 2026-07-22 | 4 | 4 | 2026-07-20 |
| 2026-07-22 | 4 | 4 | 2026-07-20 |
| 2026-07-21 | 8-K | 8-K items 7.01,9.01 | 2026-07-20 |
| 2026-07-20 | 144 | 144 | |
| 2026-06-15 | 4 | OWNERSHIP DOCUMENT | 2026-06-12 |
| 2026-06-15 | 4 | OWNERSHIP DOCUMENT | 2026-06-12 |
| 2026-06-15 | 4 | OWNERSHIP DOCUMENT | 2026-06-12 |
| 2026-06-15 | 4 | OWNERSHIP DOCUMENT | 2026-06-12 |
| 2026-06-15 | 4 | OWNERSHIP DOCUMENT | 2026-06-12 |
Forms on file (last 1,000): 4 80, 8-K 53, 3 20, 10-Q 10, SCHEDULE 13G/A 7, CORRESP 7, SC 13G 7, D 7. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=SGMT (0.002 USD), /gw/filings/filings?ticker=SGMT&form=8-K, /gw/filings/facts?ticker=SGMT&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange